HEADER OXIDOREDUCTASE/OXIDOREDUCTASE INHIBITOR 30-MAY-14 4QI9 TITLE CRYSTAL STRUCTURE OF DIHYDROFOLATE REDUCTASE FROM YERSINIA PESTIS TITLE 2 COMPLEXED WITH METHOTREXATE COMPND MOL_ID: 1; COMPND 2 MOLECULE: DIHYDROFOLATE REDUCTASE; COMPND 3 CHAIN: A, B, C; COMPND 4 EC: 1.5.1.3; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: YERSINIA PESTIS; SOURCE 3 ORGANISM_TAXID: 214092; SOURCE 4 STRAIN: CO92; SOURCE 5 GENE: FOLA, Y3688, YPO0486, YP_3693; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21 MAGIC; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PMCSG28 KEYWDS STRUCTURAL GENOMICS, CENTER FOR STRUCTURAL GENOMICS OF INFECTIOUS KEYWDS 2 DISEASES, CSGID, ALPHA BETA FOLD, NIAID, NATIONAL INSTITUTE OF KEYWDS 3 ALLERGY AND INFECTIOUS DISEASES, OXIDOREDUCTASE-OXIDOREDUCTASE KEYWDS 4 INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR N.MALTSEVA,Y.KIM,M.MAKOWSKA-GRZYSKA,R.MULLIGAN,S.SHATSMAN, AUTHOR 2 W.F.ANDERSON,A.JOACHIMIAK,CENTER FOR STRUCTURAL GENOMICS OF AUTHOR 3 INFECTIOUS DISEASES (CSGID) REVDAT 3 06-DEC-23 4QI9 1 REMARK REVDAT 2 20-SEP-23 4QI9 1 REMARK SEQADV LINK REVDAT 1 02-JUL-14 4QI9 0 JRNL AUTH N.MALTSEVA,Y.KIM,M.MAKOWSKA-GRZYSKA,R.MULLIGAN,S.SHATSMAN, JRNL AUTH 2 W.F.ANDERSON,A.JOACHIMIAK JRNL TITL CRYSTAL STRUCTURE OF DIHYDROFOLATE REDUCTASE FROM YERSINIA JRNL TITL 2 PESTIS COMPLEXED WITH METHOTREXATE JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: DEV_1593) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 34.24 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 96.6 REMARK 3 NUMBER OF REFLECTIONS : 26796 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.193 REMARK 3 R VALUE (WORKING SET) : 0.191 REMARK 3 FREE R VALUE : 0.236 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.050 REMARK 3 FREE R VALUE TEST SET COUNT : 1353 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 34.2449 - 4.9449 1.00 2653 158 0.1638 0.2046 REMARK 3 2 4.9449 - 3.9268 1.00 2651 154 0.1395 0.1643 REMARK 3 3 3.9268 - 3.4309 0.97 2537 131 0.1923 0.2482 REMARK 3 4 3.4309 - 3.1175 1.00 2647 123 0.2050 0.2585 REMARK 3 5 3.1175 - 2.8941 1.00 2640 148 0.2292 0.2752 REMARK 3 6 2.8941 - 2.7236 1.00 2652 148 0.2322 0.2703 REMARK 3 7 2.7236 - 2.5872 1.00 2601 137 0.2220 0.2785 REMARK 3 8 2.5872 - 2.4746 0.97 2536 128 0.2235 0.3056 REMARK 3 9 2.4746 - 2.3794 0.90 2395 117 0.2120 0.2862 REMARK 3 10 2.3794 - 2.2970 0.82 2131 109 0.2147 0.2756 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.300 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 25.220 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 28.40 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 30.70 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.008 3982 REMARK 3 ANGLE : 1.253 5397 REMARK 3 CHIRALITY : 0.054 558 REMARK 3 PLANARITY : 0.007 710 REMARK 3 DIHEDRAL : 17.084 1454 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4QI9 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 02-JUN-14. REMARK 100 THE DEPOSITION ID IS D_1000086088. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 02-DEC-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 19-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97918 REMARK 200 MONOCHROMATOR : SI(111) REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-3000 REMARK 200 DATA SCALING SOFTWARE : HKL-3000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 27632 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.297 REMARK 200 RESOLUTION RANGE LOW (A) : 89.559 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 4.400 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.06600 REMARK 200 FOR THE DATA SET : 11.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.34 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.6 REMARK 200 DATA REDUNDANCY IN SHELL : 4.30 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.20500 REMARK 200 FOR SHELL : 6.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: HKL-3000, MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 3Q1H REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 55.05 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.74 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2 M CALCIUM ACETATE, 0.1 M MES, PH REMARK 280 6.0, 20% PEG8000, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 289K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 89.09800 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 51.82050 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 89.09800 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 51.82050 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 16 REMARK 465 MSE A 17 REMARK 465 GLU A 18 REMARK 465 ASN A 19 REMARK 465 ALA A 20 REMARK 465 MSE A 21 REMARK 465 PRO A 22 REMARK 465 TRP A 23 REMARK 465 HIS A 24 REMARK 465 GLY B 16 REMARK 465 MSE B 17 REMARK 465 GLU B 18 REMARK 465 ASN B 19 REMARK 465 ALA B 20 REMARK 465 MSE B 21 REMARK 465 PRO B 22 REMARK 465 TRP B 23 REMARK 465 GLY C 16 REMARK 465 MSE C 17 REMARK 465 GLU C 18 REMARK 465 ASN C 19 REMARK 465 ALA C 20 REMARK 465 MSE C 21 REMARK 465 PRO C 22 REMARK 465 TRP C 23 REMARK 465 GLU C 119 REMARK 465 VAL C 120 REMARK 465 GLY C 121 REMARK 465 GLY C 122 REMARK 465 ASP C 123 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 123 65.94 -114.04 REMARK 500 ASN B 38 -1.01 74.88 REMARK 500 ASP B 70 106.04 -161.12 REMARK 500 GLU B 140 115.29 -161.39 REMARK 500 ALA C 10 -169.04 -102.15 REMARK 500 ASN C 38 -3.14 76.70 REMARK 500 ASP C 70 107.37 -162.17 REMARK 500 ASN C 88 43.42 -101.72 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MTX A 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MTX B 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MTX C 201 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3Q1H RELATED DB: PDB REMARK 900 DIHYDROFOLATE REDUCTASE WITHOUT LIGAND REMARK 900 RELATED ID: CSGID-IDP90544 RELATED DB: TARGETTRACK DBREF 4QI9 A 1 160 UNP Q7CG83 Q7CG83_YERPE 1 160 DBREF 4QI9 B 1 160 UNP Q7CG83 Q7CG83_YERPE 1 160 DBREF 4QI9 C 1 160 UNP Q7CG83 Q7CG83_YERPE 1 160 SEQADV 4QI9 GLY A 161 UNP Q7CG83 EXPRESSION TAG SEQADV 4QI9 GLU A 162 UNP Q7CG83 EXPRESSION TAG SEQADV 4QI9 ASN A 163 UNP Q7CG83 EXPRESSION TAG SEQADV 4QI9 LEU A 164 UNP Q7CG83 EXPRESSION TAG SEQADV 4QI9 TYR A 165 UNP Q7CG83 EXPRESSION TAG SEQADV 4QI9 PHE A 166 UNP Q7CG83 EXPRESSION TAG SEQADV 4QI9 GLN A 167 UNP Q7CG83 EXPRESSION TAG SEQADV 4QI9 GLY B 161 UNP Q7CG83 EXPRESSION TAG SEQADV 4QI9 GLU B 162 UNP Q7CG83 EXPRESSION TAG SEQADV 4QI9 ASN B 163 UNP Q7CG83 EXPRESSION TAG SEQADV 4QI9 LEU B 164 UNP Q7CG83 EXPRESSION TAG SEQADV 4QI9 TYR B 165 UNP Q7CG83 EXPRESSION TAG SEQADV 4QI9 PHE B 166 UNP Q7CG83 EXPRESSION TAG SEQADV 4QI9 GLN B 167 UNP Q7CG83 EXPRESSION TAG SEQADV 4QI9 GLY C 161 UNP Q7CG83 EXPRESSION TAG SEQADV 4QI9 GLU C 162 UNP Q7CG83 EXPRESSION TAG SEQADV 4QI9 ASN C 163 UNP Q7CG83 EXPRESSION TAG SEQADV 4QI9 LEU C 164 UNP Q7CG83 EXPRESSION TAG SEQADV 4QI9 TYR C 165 UNP Q7CG83 EXPRESSION TAG SEQADV 4QI9 PHE C 166 UNP Q7CG83 EXPRESSION TAG SEQADV 4QI9 GLN C 167 UNP Q7CG83 EXPRESSION TAG SEQRES 1 A 167 MSE ILE ILE SER LEU ILE ALA ALA LEU ALA ALA ASP ARG SEQRES 2 A 167 VAL ILE GLY MSE GLU ASN ALA MSE PRO TRP HIS LEU PRO SEQRES 3 A 167 ALA ASP LEU ALA TRP PHE LYS ARG ASN THR LEU ASN LYS SEQRES 4 A 167 PRO VAL ILE MSE GLY ARG LYS THR PHE GLU SER ILE GLY SEQRES 5 A 167 ARG PRO LEU PRO GLY ARG LEU ASN ILE VAL ILE SER SER SEQRES 6 A 167 GLN PRO GLY THR ASP GLU ARG VAL THR TRP ALA ALA SER SEQRES 7 A 167 ILE GLU GLU ALA LEU ALA PHE ALA GLY ASN ALA GLU GLU SEQRES 8 A 167 VAL MSE VAL MSE GLY GLY GLY ARG VAL TYR LYS GLN PHE SEQRES 9 A 167 LEU ASP ARG ALA ASN ARG MSE TYR LEU THR HIS ILE ASP SEQRES 10 A 167 ALA GLU VAL GLY GLY ASP THR HIS PHE PRO ASP TYR GLU SEQRES 11 A 167 PRO ASP GLU TRP GLU SER VAL PHE SER GLU PHE HIS ASP SEQRES 12 A 167 ALA ASP GLU ALA ASN SER HIS SER TYR CYS PHE GLU ILE SEQRES 13 A 167 LEU GLU ARG ARG GLY GLU ASN LEU TYR PHE GLN SEQRES 1 B 167 MSE ILE ILE SER LEU ILE ALA ALA LEU ALA ALA ASP ARG SEQRES 2 B 167 VAL ILE GLY MSE GLU ASN ALA MSE PRO TRP HIS LEU PRO SEQRES 3 B 167 ALA ASP LEU ALA TRP PHE LYS ARG ASN THR LEU ASN LYS SEQRES 4 B 167 PRO VAL ILE MSE GLY ARG LYS THR PHE GLU SER ILE GLY SEQRES 5 B 167 ARG PRO LEU PRO GLY ARG LEU ASN ILE VAL ILE SER SER SEQRES 6 B 167 GLN PRO GLY THR ASP GLU ARG VAL THR TRP ALA ALA SER SEQRES 7 B 167 ILE GLU GLU ALA LEU ALA PHE ALA GLY ASN ALA GLU GLU SEQRES 8 B 167 VAL MSE VAL MSE GLY GLY GLY ARG VAL TYR LYS GLN PHE SEQRES 9 B 167 LEU ASP ARG ALA ASN ARG MSE TYR LEU THR HIS ILE ASP SEQRES 10 B 167 ALA GLU VAL GLY GLY ASP THR HIS PHE PRO ASP TYR GLU SEQRES 11 B 167 PRO ASP GLU TRP GLU SER VAL PHE SER GLU PHE HIS ASP SEQRES 12 B 167 ALA ASP GLU ALA ASN SER HIS SER TYR CYS PHE GLU ILE SEQRES 13 B 167 LEU GLU ARG ARG GLY GLU ASN LEU TYR PHE GLN SEQRES 1 C 167 MSE ILE ILE SER LEU ILE ALA ALA LEU ALA ALA ASP ARG SEQRES 2 C 167 VAL ILE GLY MSE GLU ASN ALA MSE PRO TRP HIS LEU PRO SEQRES 3 C 167 ALA ASP LEU ALA TRP PHE LYS ARG ASN THR LEU ASN LYS SEQRES 4 C 167 PRO VAL ILE MSE GLY ARG LYS THR PHE GLU SER ILE GLY SEQRES 5 C 167 ARG PRO LEU PRO GLY ARG LEU ASN ILE VAL ILE SER SER SEQRES 6 C 167 GLN PRO GLY THR ASP GLU ARG VAL THR TRP ALA ALA SER SEQRES 7 C 167 ILE GLU GLU ALA LEU ALA PHE ALA GLY ASN ALA GLU GLU SEQRES 8 C 167 VAL MSE VAL MSE GLY GLY GLY ARG VAL TYR LYS GLN PHE SEQRES 9 C 167 LEU ASP ARG ALA ASN ARG MSE TYR LEU THR HIS ILE ASP SEQRES 10 C 167 ALA GLU VAL GLY GLY ASP THR HIS PHE PRO ASP TYR GLU SEQRES 11 C 167 PRO ASP GLU TRP GLU SER VAL PHE SER GLU PHE HIS ASP SEQRES 12 C 167 ALA ASP GLU ALA ASN SER HIS SER TYR CYS PHE GLU ILE SEQRES 13 C 167 LEU GLU ARG ARG GLY GLU ASN LEU TYR PHE GLN MODRES 4QI9 MSE A 1 MET SELENOMETHIONINE MODRES 4QI9 MSE A 43 MET SELENOMETHIONINE MODRES 4QI9 MSE A 93 MET SELENOMETHIONINE MODRES 4QI9 MSE A 95 MET SELENOMETHIONINE MODRES 4QI9 MSE A 111 MET SELENOMETHIONINE MODRES 4QI9 MSE B 1 MET SELENOMETHIONINE MODRES 4QI9 MSE B 43 MET SELENOMETHIONINE MODRES 4QI9 MSE B 93 MET SELENOMETHIONINE MODRES 4QI9 MSE B 95 MET SELENOMETHIONINE MODRES 4QI9 MSE B 111 MET SELENOMETHIONINE MODRES 4QI9 MSE C 1 MET SELENOMETHIONINE MODRES 4QI9 MSE C 43 MET SELENOMETHIONINE MODRES 4QI9 MSE C 93 MET SELENOMETHIONINE MODRES 4QI9 MSE C 95 MET SELENOMETHIONINE MODRES 4QI9 MSE C 111 MET SELENOMETHIONINE HET MSE A 1 8 HET MSE A 43 8 HET MSE A 93 8 HET MSE A 95 8 HET MSE A 111 8 HET MSE B 1 8 HET MSE B 43 8 HET MSE B 93 8 HET MSE B 95 8 HET MSE B 111 8 HET MSE C 1 8 HET MSE C 43 8 HET MSE C 93 8 HET MSE C 95 8 HET MSE C 111 8 HET MTX A 201 33 HET MTX B 201 33 HET MTX C 201 33 HETNAM MSE SELENOMETHIONINE HETNAM MTX METHOTREXATE FORMUL 1 MSE 15(C5 H11 N O2 SE) FORMUL 4 MTX 3(C20 H22 N8 O5) FORMUL 7 HOH *80(H2 O) HELIX 1 1 ALA A 10 VAL A 14 5 5 HELIX 2 2 PRO A 26 LEU A 37 1 12 HELIX 3 3 ARG A 45 GLY A 52 1 8 HELIX 4 4 SER A 78 ALA A 86 1 9 HELIX 5 5 GLY A 97 LEU A 105 1 9 HELIX 6 6 ASP A 106 ALA A 108 5 3 HELIX 7 7 GLU A 130 ASP A 132 5 3 HELIX 8 8 ALA B 10 VAL B 14 5 5 HELIX 9 9 LEU B 25 LEU B 37 1 13 HELIX 10 10 ARG B 45 GLY B 52 1 8 HELIX 11 11 SER B 78 ALA B 86 1 9 HELIX 12 12 GLY B 97 LEU B 105 1 9 HELIX 13 13 GLU B 130 ASP B 132 5 3 HELIX 14 14 ALA C 10 VAL C 14 5 5 HELIX 15 15 LEU C 25 LEU C 37 1 13 HELIX 16 16 ARG C 45 GLY C 52 1 8 HELIX 17 17 SER C 78 ALA C 86 1 9 HELIX 18 18 GLY C 97 LEU C 105 1 9 HELIX 19 19 GLU C 130 ASP C 132 5 3 SHEET 1 A 8 THR A 74 ALA A 76 0 SHEET 2 A 8 LEU A 59 ILE A 63 1 N VAL A 62 O THR A 74 SHEET 3 A 8 PRO A 40 GLY A 44 1 N VAL A 41 O LEU A 59 SHEET 4 A 8 GLU A 91 VAL A 94 1 O MSE A 93 N ILE A 42 SHEET 5 A 8 ILE A 2 LEU A 9 1 N SER A 4 O VAL A 94 SHEET 6 A 8 ARG A 110 ILE A 116 1 O TYR A 112 N LEU A 5 SHEET 7 A 8 TYR A 152 ARG A 159 -1 O GLU A 155 N LEU A 113 SHEET 8 A 8 TRP A 134 HIS A 142 -1 N GLU A 135 O GLU A 158 SHEET 1 B 8 THR B 74 ALA B 76 0 SHEET 2 B 8 LEU B 59 ILE B 63 1 N VAL B 62 O THR B 74 SHEET 3 B 8 PRO B 40 GLY B 44 1 N VAL B 41 O LEU B 59 SHEET 4 B 8 GLU B 91 VAL B 94 1 O MSE B 93 N ILE B 42 SHEET 5 B 8 ILE B 2 LEU B 9 1 N SER B 4 O VAL B 94 SHEET 6 B 8 ARG B 110 ILE B 116 1 O ILE B 116 N LEU B 9 SHEET 7 B 8 TYR B 152 ARG B 159 -1 O GLU B 155 N LEU B 113 SHEET 8 B 8 TRP B 134 HIS B 142 -1 N GLU B 135 O GLU B 158 SHEET 1 C 8 THR C 74 ALA C 76 0 SHEET 2 C 8 LEU C 59 ILE C 63 1 N VAL C 62 O THR C 74 SHEET 3 C 8 PRO C 40 GLY C 44 1 N VAL C 41 O LEU C 59 SHEET 4 C 8 GLU C 91 VAL C 94 1 O MSE C 93 N PRO C 40 SHEET 5 C 8 ILE C 2 LEU C 9 1 N SER C 4 O VAL C 94 SHEET 6 C 8 ARG C 110 ILE C 116 1 O ILE C 116 N LEU C 9 SHEET 7 C 8 TYR C 152 ARG C 159 -1 O GLU C 155 N LEU C 113 SHEET 8 C 8 TRP C 134 HIS C 142 -1 N GLU C 135 O GLU C 158 LINK C MSE A 1 N ILE A 2 1555 1555 1.33 LINK C ILE A 42 N MSE A 43 1555 1555 1.33 LINK C MSE A 43 N GLY A 44 1555 1555 1.34 LINK C VAL A 92 N MSE A 93 1555 1555 1.33 LINK C MSE A 93 N VAL A 94 1555 1555 1.33 LINK C VAL A 94 N MSE A 95 1555 1555 1.32 LINK C MSE A 95 N GLY A 96 1555 1555 1.33 LINK C ARG A 110 N MSE A 111 1555 1555 1.33 LINK C MSE A 111 N TYR A 112 1555 1555 1.33 LINK C MSE B 1 N ILE B 2 1555 1555 1.33 LINK C ILE B 42 N MSE B 43 1555 1555 1.34 LINK C MSE B 43 N GLY B 44 1555 1555 1.34 LINK C VAL B 92 N MSE B 93 1555 1555 1.34 LINK C MSE B 93 N VAL B 94 1555 1555 1.33 LINK C VAL B 94 N MSE B 95 1555 1555 1.32 LINK C MSE B 95 N GLY B 96 1555 1555 1.33 LINK C ARG B 110 N MSE B 111 1555 1555 1.32 LINK C MSE B 111 N TYR B 112 1555 1555 1.33 LINK C MSE C 1 N ILE C 2 1555 1555 1.33 LINK C ILE C 42 N MSE C 43 1555 1555 1.34 LINK C MSE C 43 N GLY C 44 1555 1555 1.33 LINK C VAL C 92 N MSE C 93 1555 1555 1.33 LINK C MSE C 93 N VAL C 94 1555 1555 1.32 LINK C VAL C 94 N MSE C 95 1555 1555 1.33 LINK C MSE C 95 N GLY C 96 1555 1555 1.33 LINK C ARG C 110 N MSE C 111 1555 1555 1.33 LINK C MSE C 111 N TYR C 112 1555 1555 1.33 CISPEP 1 GLY A 96 GLY A 97 0 2.33 CISPEP 2 GLY B 96 GLY B 97 0 4.59 CISPEP 3 GLY C 96 GLY C 97 0 -4.51 SITE 1 AC1 13 ILE A 6 ALA A 7 ASP A 28 PHE A 32 SITE 2 AC1 13 LYS A 33 ARG A 53 LEU A 55 ARG A 58 SITE 3 AC1 13 MSE A 95 TYR A 101 THR A 114 HOH A 303 SITE 4 AC1 13 HOH A 305 SITE 1 AC2 12 ILE B 6 ALA B 7 ALA B 8 ASP B 28 SITE 2 AC2 12 LYS B 33 ARG B 53 ARG B 58 MSE B 95 SITE 3 AC2 12 TYR B 101 THR B 114 HOH B 302 HOH B 317 SITE 1 AC3 13 ILE C 6 ALA C 7 ALA C 8 ASP C 28 SITE 2 AC3 13 PHE C 32 LYS C 33 ARG C 53 LEU C 55 SITE 3 AC3 13 ARG C 58 MSE C 95 TYR C 101 THR C 114 SITE 4 AC3 13 HOH C 318 CRYST1 178.196 103.641 34.288 90.00 93.00 90.00 C 1 2 1 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.005612 0.000000 0.000294 0.00000 SCALE2 0.000000 0.009649 0.000000 0.00000 SCALE3 0.000000 0.000000 0.029205 0.00000 HETATM 1 N MSE A 1 -9.058 -38.540 7.474 1.00 35.77 N HETATM 2 CA MSE A 1 -10.135 -39.440 7.081 1.00 29.34 C HETATM 3 C MSE A 1 -9.705 -40.892 7.110 1.00 34.08 C HETATM 4 O MSE A 1 -8.745 -41.263 6.446 1.00 36.47 O HETATM 5 CB MSE A 1 -10.619 -39.130 5.670 1.00 37.76 C HETATM 6 CG MSE A 1 -11.803 -39.984 5.249 1.00 32.95 C HETATM 7 SE MSE A 1 -12.184 -39.719 3.364 0.36 37.69 SE HETATM 8 CE MSE A 1 -12.929 -37.938 3.448 1.00 32.16 C